Literature DB >> 26411702

Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.

Allan Loh1, Yih Ching Ong1, Victoria L Blair1, Lukasz Kedzierski2,3, Philip C Andrews4.   

Abstract

Eight bismuth(III) complexes derived from the simple α-hydroxycarboxylic acids; gluconic (H₆-glu), tartaric (H₄-tar), mandelic (H₂-man), malic (H₃-mal) and glycolic (H₂-gly) have been synthesised and characterised. The complexes are formed through direct treatment of the organic acids with Bi(NO₃)3·5H₂O ([Bi(H₂-tar)(H₃- tar)] 2, [Bi(mal)(NO₃)(H₂O)₂] 6, [Bi(gly)(NO₃)(H₂O)] 8) or Bi(OtBu)₃ ([Bi(H-tar)(H₂O)₂] 1, [Bi(man)(H-man) (H₂O)] 4, [Bi2(H-mal)₃] 5, [Bi(gly)(H-gly)] 7), or through metathesis of the sodium salts with Bi(NO₃)3·5H₂O ([Bi(H3-glu)]₃). Reactions with both glucuronic and mucic acid proved to be unsuccessful. Small crystals of [Bi(gly)4(NO₃)4(H₂O)₄]·5H₂O 8 were obtained from aqueous solution and analysed by synchrotron X-ray diffraction. The data were relatively poor but composition and connectivity were established, confirming and supporting other analyses. Those complexes which displayed sufficient solubility; 2, 4, 7 and 8, were tested for their anti-Leishmanial activity against parasite promastigotes and amastigotes, and for toxicity against human fibroblast cells. All four complexes and their parent acids showed no toxicity towards either the promastigotes or fibroblast cells. However, the two glycolate complexes showed selective toxicity towards amastigotes with complex 8 providing for a low % viability of 1.8 ± 0.9 at 50.0 μM. Graphical Abstract Novel bismuth(III) complexes derived from α-hydroxycarboxylic acids have been synthesised, characterised and assessed for their anti-leishmanial activity. The glycolate complexes are selectively toxic against parasite amastigotes, with all complexes being nontoxic towards promastigotes and human fibroblast cells.

Entities:  

Keywords:  Bismuth; Glycolate; Leishmania; Toxicity; α-Hydroxycarboxylic acid

Mesh:

Substances:

Year:  2015        PMID: 26411702     DOI: 10.1007/s00775-015-1299-6

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  30 in total

1.  Bioinorganic chemistry of bismuth and antimony: target sites of metallodrugs.

Authors:  Ruiguang Ge; Hongzhe Sun
Journal:  Acc Chem Res       Date:  2007-03-02       Impact factor: 22.384

2.  Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.

Authors:  Teresa del Rosal; Fernando Baquero Artigao; Maria J Garcia Miguel; Raul de Lucas; Fernando del Castillo
Journal:  J Trop Pediatr       Date:  2009-08-05       Impact factor: 1.165

3.  Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis.

Authors:  M L Rodrigues; R S Costa; C S Souza; N T Foss; A M Roselino
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1999 Jan-Feb       Impact factor: 1.846

4.  Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes.

Authors:  J D Berman; J V Gallalee; J M Best
Journal:  Biochem Pharmacol       Date:  1987-01-15       Impact factor: 5.858

5.  A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue.

Authors:  J Mikus; D Steverding
Journal:  Parasitol Int       Date:  2000-01       Impact factor: 2.230

Review 6.  Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.

Authors:  Luiz F Oliveira; Armando O Schubach; Maria M Martins; Sônia L Passos; Raquel V Oliveira; Mauro C Marzochi; Carlos A Andrade
Journal:  Acta Trop       Date:  2011-03-21       Impact factor: 3.112

7.  Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin.

Authors:  Benjamin Gourbal; Niluefer Sonuc; Hiranmoy Bhattacharjee; Danielle Legare; Shyam Sundar; Marc Ouellette; Barry P Rosen; Rita Mukhopadhyay
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

8.  Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis.

Authors:  N C Hepburn; I Siddique; A F Howie; G J Beckett; P C Hayes
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184

9.  Interactions of oxaliplatin with the cytoplasmic thiol containing ligand glutathione.

Authors:  Tamer Shoeib; Barry L Sharp
Journal:  Metallomics       Date:  2012-12       Impact factor: 4.526

Review 10.  Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies.

Authors:  Paul A Bates
Journal:  Int J Parasitol       Date:  2007-04-18       Impact factor: 3.981

View more
  1 in total

1.  Water-Soluble Bismuth(III) Polynuclear Tyrosinehydroximate Metallamacrocyclic Complex: Structural Parallels to Lanthanide Metallacrowns.

Authors:  Marina A Katkova; Grigory Y Zhigulin; Roman V Rumyantcev; Galina S Zabrodina; Vladimir R Shayapov; Maxim N Sokolov; Sergey Y Ketkov
Journal:  Molecules       Date:  2020-09-23       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.